| |
| AAIPharma |
| Abbott Laboratoy |
| Addex Pharmaceuticals |
| ADDS |
| Adriacell S.p.A. |
| AFFICHEM |
| Affitech |
| Algen Biopharmaceuticals |
| Almac Discovery |
| ALTRAN |
| ANIMASCOPE |
| Antellis |
| ARGENE |
| Ariana Pharma |
| ARIEGE EXPANSION |
| AstraZeneca |
| ATLANTIC BONE SCREEN |
| Auvergne Biocluster |
| Avogadro |
| B Cell Design |
| Bavarian Nordic A/S |
| Bayer Health Care |
| Bayer Schering Pharma |
| Beijing Yiling Pharmaceutical Co., Ltd |
| BerGenBio AS |
| Bioam Gestion |
| BioCancell Therapeutics |
| Biocat, BioRegió de Catalunya |
| BioCentury |
| BioCentury Publications Inc. |
| BioClinica |
| BIOMEDICAL AND GLOBAL CLINICAL SOLUTIONS |
| BIOMERIEUX |
| Biomnis |
| Biotec Pharmacon ASA |
| Biotech Business Ltd |
| Biothera |
| Bristol-Myers Squibb |
| BT Pharma |
| C.RIS Pharma |
| Cambrex Pharma |
| CANCER BIO SANTE CLUSTER |
| Cancer-Bio-Sante Cluster |
| Cancer-Bio-Santé Cluster |
| Canceropole Grand Sud Ouest |
| Cancéropôle Grand Sud Ouest |
| Castres-Mazamet Technopole |
| Catalan Institute of Oncology |
| Cayla-InvivoGen |
| CCI Of Toulouse |
| CCI of Toulouse / Industry & Services Commission |
| Celgene Corporation |
| CELLVAX |
| Centro Nacional de Investigaciones Oncológicas (CNIO) |
| Cepheid Europe |
| CHELATEC |
| CHU Toulouse |
| Clavis Pharma ASA |
| CLEAN CELLS SAS |
| Clinical Reach Drug Development b.v. |
| CNRS IPBS |
| Communauté Urbaine du Grand Toulouse |
| CRC Centre d’Imatge Molecular |
| CRCI MIDI PYRENEES |
| CREATE Health |
| dafra pharma international |
| Debiopharm SA |
| DGCIS |
| DGCIS/SI |
| DiaGenic ASA |
| DIRECTION REGIONALE DU COMMERCE EXTERIEUR |
| EJ Palmer Consulting |
| Elara Pharmaceuticals |
| Elara Pharmaceuticals GmbH |
| ElexoPharm GmbH |
| Ephoran Multi Imaging Solutions |
| Epitarget AS |
| Eurasanté - EuroBiO |
| Evolife Laboratoires |
| Fa Dièse 2 |
| Fluofarma |
| FONDATION INNABIOSANTE |
| Fondation SILAB Jean Paufique |
| FONDEREPHAR |
| Foundation for Biomedical Research and Innovation |
| French Norwegian Foundation - FFN/FNS |
| Fresenius Kabi Austria GmbH |
| Frost & Sullivan |
| Fulcrum Pharma |
| Fulcrum Pharma Europe Ltd |
| Fundacio Clinic per a la Recerca Biomedica - Biocat |
| Ge Healthcare |
| genclis |
| GENCLIS SAS |
| German Cancer Research Center DKFZ |
| GLYCODE |
| grunberg |
| GSK |
| GTP Technology |
| HBM Partners |
| HUNT Biosciences |
| Hybrigenics |
| ICELLTIS |
| ICR |
| ICT Biosciences |
| Ikerchem Ltd |
| Imclone |
| ImmunID |
| INNOPSYS |
| Innovation Norway |
| INSERM |
| Inserm Transfert Initiative |
| INSERM-ADRTLS |
| Institut Claudius Regaud |
| Institut Gustave Roussy |
| Institute for Cancer Research, Dept. of Cancer Prevention, Radium Hospital, |
| IPATIMUP |
| IRDI / ICSO PE |
| KAYENTIS |
| Kurma Biofund/NLS Partners |
| LAAS-CNRS |
| Laboratoires Pierre Fabre |
| Laboratory of Experimental Medicine |
| Leitat Technological Center - Biomed Division |
| LFB |
| Light Sciences Oncology |
| Lund Univeristy |
| Lund University |
| Lytix Biopharma |
| MAGELLUIM |
| MATIMOP- Israeli Industry Centre for R&D |
| Merck |
| Merck KGaA |
| Merck-Serono |
| MERCY SPECIALIST HOSPITAL |
| METABOLYS |
| Micromedic Technologies Ltd. |
| Midi Capital |
| Midi-Pyrénées Innovation |
| MilleGen |
| MINISTERE DE LA SANTE HYGIENE PUBLIQUE HOPITAL KINDIA |
| MP5 |
| Nanjing Aosaikang Medicinal Group Co., Ltd |
| Norwegian Radium Hospital |
| NOVARTIS FARMA SPA |
| Novartis Norge AS |
| Novartis Pharmaceuticals Corporation |
| Omega Mediation Clinical Research Services GmbH (SIRO Group) |
| ONCOMEDICS |
| Optimata Ltd |
| ORALANCE PHARMA |
| OROXCELL |
| OSEO |
| Oslo Cancer Cluster |
| Oslo Teknopol |
| Oslo University Hospital |
| PCI Biotech |
| Photocure |
| PhysioStim |
| Pierre Fabre |
| Pôle Cancer-Bio-Santé |
| Pôle de Compétitivité Cancer-Bio-Santé |
| Prestwick Chemical |
| Prof. Jesper Zeuthen |
| Protherics/BTG PLC |
| Quest Management |
| QUIDD |
| QureInvest AG |
| RDC Therapeutics |
| Republik Communications Oslo |
| Research group of Integrative Biochemistry and Cancer Therapy, Universitat de Barcelona |
| Rigshospitalet |
| Roche |
| Ruggero Della Bitta |
| sanofi- aventis |
| Sanofi Aventis R&D |
| Sareum Ltd |
| schwartz communications |
| SEED Capital Denmark |
| Seed Capital Denmark K/S |
| SETRAD (Sino-European Theurapeutical R&D) |
| SFI-CAST - Centre for Resarch Based Innovation - Cancer Stem Cell Innovation Center |
| Shaligal Promotion Ltd |
| Sicoval |
| Silenseed LTD |
| siRNAsense AS |
| Skuldtech |
| Sochinaz SA |
| Sofinnova Partners |
| Spirogen Ltd |
| STATITEC |
| Sunstone Capital |
| SuperGen |
| SymbioTec GmbH |
| SYNELVIA |
| Synthon BV |
| TECKNOWMETRIX |
| TEKNIMED |
| Teva Phamaceuticals Europe B.V. |
| The Hebrew University of Jerusalem |
| The MarkeTech Group |
| The Norwegian Cancer Registry |
| The Norwegian Radium Hospital Research Foundation |
| TRANSGENE |
| United Nations Millennium Development goals Nepal |
| Université Paul Sabatier |
| University Hospital Heidelberg |
| University of Oslo |
| University of Oslo -The Centre for Entrepreneurship |
| University of Oslo, Centre for Entrepreneurship |
| URODELIA |
| VacciGuard |
| VALIDAPRO EUROPE |
| Vectalys |
| ViroStatics srl |
| VOXCAN |
| Wiborg ApS |
| |
